Bibian van der Voorn

117 GR/MR VARIATION ON IQ & BEHAVIOR AFTER PREMATURITY REFERENCES 1. De Kieviet JF, Zoetebier L, van Elburg RM, Vermeulen RJ, Oosterlaan J. Brain development of very preterm and very low-birthweight children in childhood and adolescence: a meta-analysis. Dev Med Child Neurol 54 :313-23 (2012). 2. Aylward GP. Neurodevelopmental outcomes of infants born prematurely. J Dev Behav Pediatr 26 :427-40 (2005). 3. Connors SL, Levitt P, Matthews SG, SlotkinTA, Johnston MV, Kinney HC, JohnsonWG, Dailey RM, Zimmerman AW. Fetal mechanisms in neurodevelopmental disorders. Pediatr Neurol 38 :163–76 (2008). 4. Khulan B, Drake AJ. Glucocorticoids as mediators of developmental programming effects. Best Pract Res Clin Endocrinol Metab 26 :689–700 (2012). 5. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 3 :CD004454 (2006). 6. Dessens A, Haas HS, Koppe J. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics 105 :E77 (2000). 7. Dalziel SR, LimVK, Lambert A, McCarthy D, ParagV, Rodgers A, Harding JE. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ 331 :665 (2005). 8. MacArthur B, Howie R, Dezoete J, Elkins J. Cognitive and psychosocial development of 4-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 68 :638-43 (1981). 9. Bethesda. Effects of antenatal dexamethasone administration in the infant : Long-term follow-up. J Pediatr 104 :259–267 (1984). 10. Salokorpi T, Sajaniemi N, Hällback H, Kari A, Rita H, von Wendt L. Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years. Acta Paediatr 86 :294–8 (1997). 11. Derijk RH. Single nucleotide polymorphisms related to HPA axis reactivity. Neuroimmunomodulation 16 :340–52 (2009). 12. Matthews SG. Antenatal glucocorticoids and programming of the developing CNS. Pediatr Res 47 :291–300 (2000). 13. Kang HJ, Kawasawa YI, Cheng F, Zhu Y, Xu X, Li M, Sousa AM, Pletikos M, Meyer KA, Sedmak G, Guennel T, Shin Y, Johnson MB, Krsnik Z, Mayer S, Fertuzinhos S, Umlauf S, Lisgo SN, Vortmeyer A, Weinberger DR, Mane S, Hyde TM, Huttner A, Reimers M, Kleinman JE, Sestan N. Spatio- temporal transcriptome of the human brain. Nature 478 :483–9 (2011). 14. Kuningas M, de Rijk RH, Westendorp RGJ, Jolles J, Slagboom PE, van Heemst D. Mental performance in old age dependent on cortisol and genetic variance in the mineralocorticoid and glucocorticoid receptors. Neuropsychopharmacology 32 :1295–301 (2007). 15. Manenschijn L, van den Akker ELT, Lamberts SWJ, van Rossum EFC. Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann N Y Acad Sci 1179 :179–98 (2009). 16. Russcher H, Smit P, van den Akker EL, van Rossum EF, Brinkmann AO, de Jong FH, Lamberts SW, Koper JW. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J Clin Endocrinol Metab 90 :5804–10 (2005). 17. Van Leeuwen N, Kumsta R, Entringer S, de Kloet ER, Zitman FG, DeRijk RH, Wüst S. Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology 35 :339–49 (2010). 18. Veen S, Ens-Dokkum MH, Schreuder AM, Verloove- Vanhorick SP, Brand R, Ruys JH. Impairments, disabilities, and handicaps of very preterm and very-low-birthweight infants at five years of age. Lancet 338 :33–36 (1991). 19. Hille ETM, Elbertse L, Gravenhorst JB, Brand R, Verloove- Vanhorick SP. Nonresponse bias in a follow-up study of 19-year-old adolescents born as preterm infants. Pediatrics 116 :e662–6 (2005). 20. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet 363:1728–31 (2004). 21. Finken MJ, Keijzer-Veen MG, Dekker FW, Frölich M,Walther FJ, Romijn JA, Van der Heijden BJ, Wit JM. Antenatal glucocorticoid treatment is not associated with long- term metabolic risks in individuals born before 32 weeks of gestation. Arch Dis Child Fetal Neonatal Ed 93 :F442–7 (2008). 22. Bleichrodt N, van den Berg RH. Multicultural Capacity Test: Intermediate Level (MCT-M) —Manual. Amsterdam, Netherlands: NOA-VU (2000).